Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    2010EAP
Show Display Options
Rank Status Study
1 No longer available An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
Condition: Breast Cancer
Intervention: Drug: iniparib
2 Completed Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
Condition: Myocardial Infarction
Interventions: Drug: FDC;   Drug: Separately drugs, simvastatin, aspirin and ramipril

Indicates status has not been verified in more than two years